---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-017112"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2024-04-22T23:59:59+00:00"
generated_at: "2026-06-03T13:38:20.420668+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aquestive Therapeutics raises $77.5M in public offering; over-allotment exercised

## Summary
- Underwriters exercised over-allotment for 559,801 shares at $4.50 on April 22, 2024.
- Total gross proceeds approximate $77.5M from 17.2M shares issued.
- Offering co-managed by Leerink Partners, Piper Sandler; Oppenheimer as lead manager.
- Over-allotment exercised 30 days after initial closing of March 22, 2024.

## SEC filing metadata
- accession: 0001628280-24-017112
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2024-04-22T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828024017112/0001628280-24-017112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024017112/aqst-20240422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-017112
- JSON: https://secwatch.observer/filing/0001628280-24-017112.json
- Plain text: https://secwatch.observer/filing/0001628280-24-017112.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.